Eli Lilly | Процентные Расходы



Interest Expense On Debt Изменить Дата
AbbVie USD 610M 19M 2024-12
Abbott USD 45M 6M 2024-12
ALKERMES USD 4.65M 1.35M 2024-12
Amgen USD 747M 29M 2024-12
AstraZeneca 429M 28M 2024-12
Baxter International USD 100M 1000K 2024-12
Biogen USD 60M 200K 2024-12
Bristol-Myers Squibb USD 496M 9M 2024-12
Drreddys Laboratories INR 817M 60M 2024-12
Eli Lilly USD 224.7M 78.4M 2024-12
Gilead Sciences USD 248M 10M 2024-12
GlaxoSmithKline 173M 17M 2024-12
Glaxosmithkline 178.05M 24.73M 2024-12
Indivior 9M 1000K 2024-09
J&J USD 137M 56M 2024-12
Medtronic USD 179M 30M 2025-01
Merck USD 328M 2M 2024-12
Neurocrine Biosciences USD 1.1M 0 2024-03
Novartis USD 275M 11M 2024-12
Novartis USD 275M 11M 2024-12
Novo Nordisk 562M 40M 2024-09
Perrigo 43.1M 200K 2024-12
Pfizer USD 739M 45M 2024-12
Prestige Brands USD 11.37M 908K 2024-12
Regeneron Pharmaceuticals USD 10.5M 3.3M 2024-12
Roche Holding CHF 311.5M 1000K 2024-12
Sanofi 62M 17M 2024-12
Sanofi 66.11M 20.67M 2024-12
United Therapeutics USD 7.9M 2.2M 2024-12
Zoetis USD 51M 6M 2024-12



Eli Lilly Процентные Расходы - Текущие значения, предыдущие значения, прогнозы, графики и экономический календарь - Mar 2025.